Search icon

Gentex Pharma, LLC

Headquarter
Company claim

Is this your business?

Get access!

Company Details

Name: Gentex Pharma, LLC
Jurisdiction: MISSISSIPPI
Business Type: Limited Liability Company
Status: Good Standing
Effective Date: 13 May 2005 (20 years ago)
Business ID: 872364
ZIP code: 39232
County: Rankin
State of Incorporation: MISSISSIPPI
Principal Office Address: 232 Market Street, Building KFlowood, MS 39232

Links between entities

Type:
Headquarter of
Company Number:
000-608-797
State:
ALABAMA
ALABAMA profile:

Agent

Name Role Address
Josh McCrory Agent 200 E Government Street, Brandon, MS 39042

Manager

Name Role Address
Peter B Trebotich III Manager 211 Binnacle Court, Brandon, MS 39047

Member

Name Role Address
Peter B Trebotich III Member 211 Binnacle Court, Brandon, MS 39047

President

Name Role Address
Peter B Trebotich III President 211 Binnacle Court, Brandon, MS 39047

Central Index Key

A CIK (Central Index Key) number is a unique identifier assigned by the U.S. Securities and Exchange Commission (SEC) to companies that: Are publicly traded on U.S. stock exchanges, File reports with the SEC.

Note: Having a CIK number indicates that: The company is registered with the SEC, Files regular financial reports (like 10-K, 10-Q), Must comply with federal securities laws and regulations, Has public shareholders, Makes financial information publicly available through SEC's EDGAR database.

CIK number:
0001330223
Phone:
601-260-4685

Latest Filings

Form type:
REGDEX
File number:
021-78131
Filing date:
2005-06-13
File:

National Provider Identifier

NPI Number:
1114373586

Authorized Person:

Name:
FORD JENNINGS MUNDY
Role:
OWNER
Phone:

Taxonomy:

Selected Taxonomy:
332900000X - Non-Pharmacy Dispensing Site
Is Primary:
Yes

Contacts:

Fax:
6015109318

Filings

Type Status Filed Date Description
Annual Report LLC Filed 2025-02-03 Annual Report For Gentex Pharma, LLC
Annual Report LLC Filed 2024-11-26 Annual Report For Gentex Pharma, LLC
Annual Report LLC Filed 2024-04-24 Annual Report For Gentex Pharma, LLC
Amendment Form Filed 2024-04-24 Amendment For Gentex Pharma, LLC
Annual Report LLC Filed 2023-02-28 Annual Report For Gentex Pharma, LLC
Annual Report LLC Filed 2022-02-09 Annual Report For Gentex Pharma, LLC
Annual Report LLC Filed 2021-01-28 Annual Report For Gentex Pharma, LLC
Annual Report LLC Filed 2020-03-23 Annual Report For Gentex Pharma, LLC
Annual Report LLC Filed 2019-05-15 Annual Report For Gentex Pharma, LLC
Annual Report LLC Filed 2018-01-22 Annual Report For Gentex Pharma, LLC

Trademarks Section

Serial Number:
88165351
Mark:
ENHANCE
Status:
Abandoned because the applicant failed to respond or filed a late response to an Office action. To view all documents in this file, click on the Trademark Document Retrieval link at the top of this page.
Mark Type:
Trademark
Application Filing Date:
2018-10-23
Mark Drawing Type:
3 - AN ILLUSTRATION DRAWING WHICH INCLUDES WORD(S)/ LETTER(S) /NUMBER(S)
Mark Literal Elements:
ENHANCE

Goods And Services

For:
New topical cosmetic line that contains a high concentrated version of sodium hyaluronate
International Classes:
003 - Primary Class
Class Status:
ACTIVE

Court Cases

Court Case Summary

Filing Date:
2019-09-09
Status:
Terminated
Nature Of Judgment:
no monetary award
Jury Demand:
Neither plaintiff nor defendant demands jury
Nature Of Suit:
Other Contract Actions

Parties

Party Name:
Gentex Pharma, LLC
Party Role:
Plaintiff
Party Name:
GLYCOBIOSCIENCES, INC.,
Party Role:
Defendant

Reviews Leave a review

This company hasn't received any reviews.

Date of last update: 13 May 2025

Sources: Company Profile on Mississippi Secretary of State Website